An economic model of long-term use of celecoxib in patients with osteoarthritis

An economic model of long-term use of celecoxib in patients with osteoarthritis

<p>Abstract</p> <p>Background</p> <p>Previous evaluations of the cost-effectiveness of the cyclooxygenase-2 selective inhibitor celecoxib (Celebrex, Pfizer Inc, USA) have produced conflicting results. The recent controversy over the cardiovascular (CV) risks of rofecoxi...

Full description

Bibliographic Details
Main Authors:	Rublee Dale, Loyd Michael, Jacobs Philip
Format:	Article
Language:	English
Published:	BMC 2007-07-01
Series:	BMC Gastroenterology
Online Access:	http://www.biomedcentral.com/1471-230X/7/25

Similar Items

The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis
by: Shelbaya A, et al.
Published: (2018-04-01)

A comparative study of the efficacy of NAXOZOL compared to celecoxib in patients with osteoarthritis.
by: Moon Soo Park, et al.
Published: (2020-01-01)

Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis
by: Johnson C, et al.
Published: (2020-01-01)

Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis
by: Essex MN, et al.
Published: (2014-05-01)

Eficácia e tolerabilidade da nimesulida versus celecoxib na osteoartrite Efficacy and tolerability of nimesulide versus celecoxib in osteoarthritis
by: Nilzio Antonio da Silva, et al.
Published: (2001-03-01)

Therapeutic Efficacy of Ozone Injection into the Knee for the Osteoarthritis Patient along with Oral Celecoxib and Glucosamine
by: XU Feng, et al.
Published: (2017-09-01)

Analgesic effect and side effects of celecoxib and meloxicam in canine hip osteoarthritis
by: Víctor Molina D, et al.
Published: (2014-09-01)

Análisis coste-efectividad del empleo de celecoxib en el tratamiento de la artrosis Cost-effectiveness analysis of the use of celecoxib for the treatment of osteoarthritis
by: A. Moreno, et al.
Published: (2003-02-01)

Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis.
by: Bai-Ru Cheng, et al.
Published: (2021-01-01)

Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis
by: Notter Marianne, et al.
Published: (2008-03-01)

Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritis
by: A. R. Tellegen, et al.
Published: (2018-01-01)

Electrospun Nanofibrous Composite Membranes for Long‐Term Release of Celecoxib for Achilles Tendon Reconstruction Following Injury
by: Yi‐Hsun Yu, et al.
Published: (2023-11-01)

Development of Celecoxib Granules for Manufacturing of Prolonged Release Celecoxib Capsules and Tablets
by: A. Alkhodri, et al.
Published: (2022-02-01)

Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial
by: Chirikov VV, et al.
Published: (2021-05-01)

MULTICENTRIC OSTEOARTHRITIS INTERVENTION STUDY WITH SYSADOA (MOVES): EFFECTS OF COMBINED GLUCOSAMINE HYDROCHLORIDE AND CHONDROITIN SULFATE VS. CELECOXIB FOR PAINFUL KNEE OSTEOARTHRITIS
by: Castillo, JR, et al.
Published: (2014)

Função renal, hepática e cardíaca de cães hígidos sob terapia prolongada com celecoxibe Renal, hepatic and cardiac function in healthy dogs during long-term celecoxib therapy
by: Marina Borges, et al.
Published: (2012-10-01)

Efficacy and safety of sodium hyaluronate combined with celecoxib for knee osteoarthritis: A systematic review and meta-analysis
by: Mengjie Zeng, et al.
Published: (2024-03-01)

Psychiatric manifestations in orthopedic patients on Celecoxib therapy
by: Arumugam, Manohar, et al.
Published: (2010)

Effects of nimesulide on pain and on synovial fluid concentrations of sp, il-6, and il-8 in patients with knee osteoarthritis: comparison with celecoxib
by: Mauro Bianchi, et al.
Published: (2006-09-01)

Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib
by: Cyril Sobolewski, et al.
Published: (2021-07-01)

Inkjet printability of Celecoxib drug solutions
by: Sannan Ahmed, et al.
Published: (2023-09-01)

Allergic vasculitis associated with celecoxib.
by: Jordan, K, et al.
Published: (2002)

Hepatotoxicity induced by celecoxib and amlodipine
by: P Zinsser, et al.
Published: (2004-04-01)

Effect of Celecoxib on the Peripheral NO Production
by: Parichehr Hassanzadeh
Published: (2009-03-01)

Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib
by: Yonghyun Lee, et al.
Published: (2020-10-01)

Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis
by: Diana Ana-Maria Nițescu, et al.
Published: (2022-04-01)

Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemia.
by: Martins Ekor, et al.
Published: (2021-01-01)

Triggering of Suicidal Erythrocyte Death by Celecoxib
by: Florian Lang, et al.
Published: (2013-09-01)

Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.
by: Chun-Nan Yeh, et al.
Published: (2013-01-01)

Prospects for the use of celecoxib in patients with ankylosing spondylitis: impact on retarding disease progression
by: Yulia Leonidovna Korsakova
Published: (2012-09-01)

Combination of fasudil and celecoxib promotes the recovery of injured spinal cord in rats better than celecoxib or fasudil alone
by: Xiao-lin Hou, et al.
Published: (2015-01-01)

Osteoarthritis- a systematic review of long-term safety implications for osteoarthritis of the knee
by: Jonathon Charlesworth, et al.
Published: (2019-04-01)

S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]
by: Harvey Phillip W, et al.
Published: (2004-02-01)

Histomorphometric Quantitative Evaluation of Long-Term Risedronate Use in a Knee Osteoarthritis Rabbit Model
by: Silvia Fernández-Martín, et al.
Published: (2021-04-01)

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
by: Y Chen, et al.
Published: (2008-04-01)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
by: Abdul Qadir, MPhil, et al.
Published: (2023-10-01)

Repurposing celecoxib as a topical antimicrobial agent
by: Mohamed N. Seleem, et al.
Published: (2015-07-01)

Causal Discovery in Radiographic Markers of Knee Osteoarthritis and Prediction for Knee Osteoarthritis Severity With Attention–Long Short-Term Memory
by: Yanfei Wang, et al.
Published: (2020-12-01)

EFFECT OF LONG-TERM AFFLUTOP THERAPY ON THE ARTHROSONOGRAPHIC CHANGES IN PATIENTS WITH KNEE OSTEOARTHRITIS
by: M. S. Svetlova, et al.
Published: (2018-02-01)

Efficacy and safety of nimesulide long term administration in patients with osteoarthritis: results of 12-months open controlled study DINAMO (long term administration of nimesulide in osteoarthritis multifactor assessment)
by: L I Alexeeva, et al.
Published: (2009-08-01)